Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea D Gloor

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinics in Dermatology|July 17, 2021
Neutrophilic dermatoses with unusual and atypical presentationsLaurence Feldmeyer, Simone Ribero, Andrea D Gloor, et al.
Seminars in Immunopathology|February 10, 2022
Age as a risk factor in vasculitisAndrea D Gloor, Gerald J Berry, Jorg J Goronzy, et al.
Rheumatology (Oxford, England)|July 3, 2018
Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritisAndrea D Gloor, Daniel Yerly, Sabine Adler, et al.
Frontiers in Immunology|June 8, 2023
Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial)Lisa Christ, Andrea D Gloor, Florian Kollert, et al.
Plos One|June 18, 2021
Takayasu arteritis: Prevalence and clinical presentation in SwitzerlandAndrea D Gloor, Laurève Chollet, Lisa A Christ, et al.
Rheumatology (Oxford, England)|February 7, 2024
Serum protein profiling reveals distinct patient clusters in giant cell arteritisFlavia Zingg, Fabio S Ryser, Andrea D Gloor, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinics in Dermatology|July 17, 2021
Neutrophilic dermatoses with unusual and atypical presentationsLaurence Feldmeyer, Simone Ribero, Andrea D Gloor, et al.
Seminars in Immunopathology|February 10, 2022
Age as a risk factor in vasculitisAndrea D Gloor, Gerald J Berry, Jorg J Goronzy, et al.
Rheumatology (Oxford, England)|July 3, 2018
Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritisAndrea D Gloor, Daniel Yerly, Sabine Adler, et al.
Frontiers in Immunology|June 8, 2023
Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial)Lisa Christ, Andrea D Gloor, Florian Kollert, et al.
Plos One|June 18, 2021
Takayasu arteritis: Prevalence and clinical presentation in SwitzerlandAndrea D Gloor, Laurève Chollet, Lisa A Christ, et al.
Rheumatology (Oxford, England)|February 7, 2024
Serum protein profiling reveals distinct patient clusters in giant cell arteritisFlavia Zingg, Fabio S Ryser, Andrea D Gloor, et al.
Pageof 1